Acoustic Liver Biopsy in Normals and in Patients With Cirrhosis Using Endoscopic Ultrasound

Completed

• Conditions: Cirrhosis; Alcoholism; Hepatitis c

• Registration Number: NCT01208311
• Lead Sponsor: Northwell Health

Brief Summary

The purpose of this study is to determine the amount of fibrosis in the liver of hepatitis C patients with advanced fibrosis, using endoscopic ultrasound.

Detailed Description

Background: Transabdominal ultrasound cannot be used to quantitate fibrosis in patients with cirrhosis due to variability in the abdominal wall thickness and composition. This variability can be eliminated by using endoscopic ultrasound.

Aim: To determine the amount of fibrosis in the liver of hepatitis C patients with advanced fibrosis, using endoscopic ultrasound.

Study Timeline

• Study Start: 2004-12
• Study First Submitted: 2010-09-22
• Study First Submitted QC: 2010-09-22
• Study First Posted: 2010-09-23
• Status Verified: 2016-12
• Primary Completion: 2016-12
• Study Completion: 2016-12
• Last Update Submitted: 2016-12-28
• Last Update Posted: 2016-12-29

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 7

Inclusion Criteria

• hepatic cirrhosis and hepatitis C and undergoing endoscopy
• Alcoholic liver and undergoing endoscopy
• Normal liver undergoing endoscopy

Exclusion Criteria

• pregnancy
• Children

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Luminosity on ultrasound	Once at the time of the endoscopic ultrasound

Trial Locations

Locations (1)

LIJ Medical Center- NSLIJ Health System; 🇺🇸 New Hyde Park, New York, United States